US pharma giant Merck & Co today revealed an early stop to the Phase III HYPERION study evaluating Winrevair (sotatercept-csrk) versus placebo (both in combination with background therapy) in recently ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with ...
Institution-focused digital asset technology and trading firm BlockFills is collaborating with CoinDesk Indices to launch ...
BlockFills, a digital assets technology and trading firm for institutions and professional traders, has announced a ...
The CoinDesk 20 Index provides a benchmark for institutional investors beyond Bitcoin and Ethereum exchange-traded funds. It has gained adoption among hedge funds and asset managers since its ...
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
The initial public offering of Dr Agarwal’s Health Care that opened on Wednesday was subscribed 7% with muted response from ...
The ₹3,025-crore initial public offering of Dr Agarwal’s Health Care opens today at a price band of ₹382- ₹402. The IPO will ...
Dr Agarwals Health Care secures Rs 875.5 crore from anchor investors, including major firms, ahead of its IPO set for9-31.
Country and Town House on MSN1d
This Jacket Will Fully Biodegrade In Just 5 YearsWe’ve seen underwear made from seaweed and carbon-cutting denim dye, but what about a piece of clothing that will break down ...
5don MSN
Dr Agarwal’s Healthcare IPO opens on January 29 and closes on January 31, with a price band of ₹382 to 402 per share. The ...
Dr Agarwal’s Healthcare IPO opens for subscription on January 29, offering a range of eye care services. The firm holds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback